4523.T

Research · Aug 27, 2026

Drug Royalty Holders Turn Royalties Into Dividends

Neuren pays out 70-100% of its DAYBUE royalty after just USD3m of half-year admin cost; BioArctic paid a SEK177m dividend in June and still held about SEK2bn of cash.